AKBA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Akebia Therapeutics Inc (AKBA).


$414.54M Market Cap.

As of 03/13/2025 5:00 PM ET (MRY) • Disclaimer

AKBA Market Cap. (MRY)


AKBA Shares Outstanding (MRY)


AKBA Assets (MRY)


Total Assets

$220.67M

Total Liabilities

$269.86M

Total Investments

$0

AKBA Income (MRY)


Revenue

$160.18M

Net Income

-$69.41M

Operating Expense

$144.25M

AKBA Cash Flow (MRY)


CF Operations

-$40.66M

CF Investing

-$33.00K

CF Financing

$49.66M

AKBA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AKBA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$220,670,000 (-8.70%)

$241,703,000 (-32.12%)

$356,054,000 (-32.74%)

$529,347,000 (-17.82%)

Assets Current

$113,831,000 (-3.65%)

$118,149,000 (-36.20%)

$185,182,000 (-31.70%)

$271,149,000 (-27.00%)

Assets Non-Current

$106,839,000 (-13.53%)

$123,554,000 (-27.69%)

$170,872,000 (-33.82%)

$258,198,000 (-5.32%)

Goodwill & Intangible Assets

$59,044,000 (-37.90%)

$95,086,000 (-27.49%)

$131,128,000 (-21.56%)

$167,171,000 (-16.09%)

Shareholders Equity

-$49,185,000 (-60.82%)

-$30,584,000 (-684.78%)

$5,230,000 (-92.93%)

$74,008,000 (-70.11%)

Property Plant & Equipment Net

$10,418,000 (-35.07%)

$16,045,000 (-53.32%)

$34,372,000 (-15.35%)

$40,606,000 (14.39%)

Cash & Equivalents

$51,870,000 (20.84%)

$42,925,000 (-52.55%)

$90,466,000 (-39.61%)

$149,800,000 (-34.50%)

Accumulated Other Comprehensive Income

$6,000 (0.00%)

$6,000 (0.00%)

$6,000 (0.00%)

$6,000 (-53.85%)

Deferred Revenue

$0 (0%)

$83,389,000 (-5.27%)

$88,026,000 (107.71%)

$42,380,000 (4.49%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$16,243,000 (3.52%)

$15,691,000 (-27.25%)

$21,568,000 (-41.12%)

$36,628,000 (-39.97%)

Trade & Non-Trade Receivables

$34,368,000 (-12.53%)

$39,290,000 (-2.47%)

$40,284,000 (-21.90%)

$51,581,000 (92.09%)

Trade & Non-Trade Payables

$15,180,000 (3.72%)

$14,635,000 (-18.79%)

$18,021,000 (-46.35%)

$33,588,000 (-18.69%)

Accumulated Retained Earnings (Deficit)

-$1,678,360,000 (-4.31%)

-$1,608,950,000 (-3.33%)

-$1,557,025,000 (-6.44%)

-$1,462,799,000 (-24.23%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$42,240,000 (-3.19%)

$43,630,000 (-54.09%)

$95,039,000 (-27.59%)

$131,246,000 (8.47%)

Debt Current

$0 (0%)

$17,500,000 (-45.31%)

$32,000,000 (-67.19%)

$97,543,000 (0%)

Debt Non-Current

$42,240,000 (61.65%)

$26,130,000 (-58.55%)

$63,039,000 (87.04%)

$33,703,000 (-72.15%)

Total Liabilities

$269,855,000 (-0.89%)

$272,287,000 (-22.39%)

$350,824,000 (-22.95%)

$455,339,000 (14.83%)

Liabilities Current

$80,914,000 (-18.98%)

$99,870,000 (-22.90%)

$129,536,000 (-50.38%)

$261,051,000 (39.49%)

Liabilities Non-Current

$188,941,000 (9.58%)

$172,417,000 (-22.08%)

$221,288,000 (13.90%)

$194,288,000 (-7.21%)

AKBA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$160,180,000 (-17.70%)

$194,623,000 (-33.46%)

$292,484,000 (38.19%)

$211,650,000 (-28.17%)

Cost of Revenue

$63,177,000 (-14.80%)

$74,149,000 (-13.34%)

$85,568,000 (-43.21%)

$150,671,000 (-49.18%)

Selling General & Administrative Expense

$106,545,000 (6.30%)

$100,233,000 (-27.68%)

$138,601,000 (-20.41%)

$174,140,000 (13.01%)

Research & Development Expense

$37,652,000 (-40.31%)

$63,079,000 (-51.47%)

$129,986,000 (-12.08%)

$147,852,000 (-32.33%)

Operating Expenses

$144,255,000 (-11.77%)

$163,493,000 (-43.17%)

$287,695,000 (-11.61%)

$325,481,000 (-13.43%)

Interest Expense

$18,185,000 (201.48%)

$6,032,000 (-61.55%)

$15,687,000 (-21.31%)

$19,936,000 (124.73%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$69,410,000 (-33.67%)

-$51,925,000 (44.89%)

-$94,226,000 (66.59%)

-$282,024,000 (26.72%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$69,410,000 (-33.67%)

-$51,925,000 (44.89%)

-$94,226,000 (66.59%)

-$282,024,000 (26.72%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$69,410,000 (-33.67%)

-$51,925,000 (44.89%)

-$94,226,000 (66.59%)

-$282,024,000 (26.72%)

Weighted Average Shares

$210,946,658 (12.53%)

$187,465,448 (2.56%)

$182,782,680 (10.14%)

$165,949,695 (19.85%)

Weighted Average Shares Diluted

$210,946,658 (12.53%)

$187,465,448 (2.56%)

$182,782,680 (10.14%)

$165,949,695 (19.85%)

Earning Before Interest & Taxes (EBIT)

-$51,225,000 (-11.62%)

-$45,893,000 (41.57%)

-$78,539,000 (70.03%)

-$262,088,000 (30.29%)

Gross Profit

$97,003,000 (-19.48%)

$120,474,000 (-41.78%)

$206,916,000 (239.32%)

$60,979,000 (3426.73%)

Operating Income

-$47,252,000 (-9.84%)

-$43,019,000 (46.74%)

-$80,779,000 (69.46%)

-$264,502,000 (29.99%)

AKBA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$33,000 (0%)

$0 (0%)

-$114,000 (-100.29%)

$39,941,000 (199.84%)

Net Cash Flow from Financing

$49,663,000 (297.03%)

-$25,206,000 (-272.67%)

$14,598,000 (-89.08%)

$133,731,000 (-42.29%)

Net Cash Flow from Operations

-$40,659,000 (-73.88%)

-$23,384,000 (68.03%)

-$73,154,000 (71.08%)

-$252,965,000 (-129.16%)

Net Cash Flow / Change in Cash & Cash Equivalents

$8,971,000 (118.46%)

-$48,590,000 (17.18%)

-$58,670,000 (26.01%)

-$79,293,000 (-197.50%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$40,000,000 (200.79%)

Capital Expenditure

-$33,000 (0%)

$0 (0%)

-$114,000 (-93.22%)

-$59,000 (81.39%)

Issuance (Repayment) of Debt Securities

$7,901,000 (124.69%)

-$32,000,000 (3.03%)

-$33,000,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$43,034,000 (533.41%)

$6,794,000 (-10.58%)

$7,598,000 (-91.46%)

$88,948,000 (-57.99%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$7,775,000 (-16.55%)

$9,317,000 (-47.80%)

$17,849,000 (-21.49%)

$22,735,000 (-7.05%)

Depreciation Amortization & Accretion

$41,702,000 (-0.34%)

$41,846,000 (18.61%)

$35,280,000 (-2.35%)

$36,128,000 (10.64%)

AKBA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

60.60% (-2.10%)

61.90% (-12.45%)

70.70% (145.49%)

28.80% (4900.00%)

Profit Margin

-43.30% (-62.17%)

-26.70% (17.08%)

-32.20% (75.84%)

-133.30% (-2.07%)

EBITDA Margin

-5.90% (-180.95%)

-2.10% (85.81%)

-14.80% (86.14%)

-106.80% (8.33%)

Return on Average Equity (ROAE)

172.90% (-7.44%)

186.80% (153.28%)

-350.60% (-86.39%)

-188.10% (-62.72%)

Return on Average Assets (ROAA)

-31.80% (-54.37%)

-20.60% (-0.98%)

-20.40% (57.14%)

-47.60% (11.85%)

Return on Sales (ROS)

-32.00% (-35.59%)

-23.60% (12.27%)

-26.90% (78.27%)

-123.80% (2.98%)

Return on Invested Capital (ROIC)

-77.90% (-6.28%)

-73.30% (12.32%)

-83.60% (59.87%)

-208.30% (-8.72%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-5.76 (-30.01%)

-4.43 (-299.01%)

-1.11 (16.48%)

-1.33 (-31.98%)

Price to Sales Ratio (P/S)

2.5 (109.55%)

1.19 (230.75%)

0.36 (-79.63%)

1.77 (34.65%)

Price to Book Ratio (P/B)

-8.43 (-10.34%)

-7.64 (-137.63%)

20.3 (279.86%)

5.34 (226.99%)

Debt to Equity Ratio (D/E)

-5.49 (38.37%)

-8.9 (-113.27%)

67.08 (990.18%)

6.15 (284.32%)

Earnings Per Share (EPS)

-0.33 (-17.86%)

-0.28 (46.15%)

-0.52 (69.41%)

-1.7 (38.85%)

Sales Per Share (SPS)

0.76 (-26.88%)

1.04 (-35.13%)

1.6 (25.49%)

1.27 (-40.08%)

Free Cash Flow Per Share (FCFPS)

-0.19 (-54.40%)

-0.13 (68.83%)

-0.4 (73.70%)

-1.52 (-90.62%)

Book Value Per Share (BVPS)

-0.23 (-42.94%)

-0.16 (-662.07%)

0.03 (-93.50%)

0.45 (-75.06%)

Tangible Assets Book Value Per Share (TABVPS)

0.77 (-2.05%)

0.78 (-36.47%)

1.23 (-43.58%)

2.18 (-32.09%)

Enterprise Value Over EBIT (EV/EBIT)

-8 (-60.00%)

-5 (-400.00%)

-1 (0.00%)

-1 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-44.51 (24.93%)

-59.28 (-4320.73%)

-1.34 (0.89%)

-1.35 (-38.49%)

Asset Turnover

0.73 (-5.05%)

0.77 (22.12%)

0.63 (77.31%)

0.36 (-13.56%)

Current Ratio

1.41 (18.93%)

1.18 (-17.27%)

1.43 (37.63%)

1.04 (-47.66%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$40,692,000 (-74.02%)

-$23,384,000 (68.08%)

-$73,268,000 (71.04%)

-$253,024,000 (-128.56%)

Enterprise Value (EV)

$423,817,284 (76.65%)

$239,913,875 (313.54%)

$58,015,122 (-81.02%)

$305,693,533 (-8.89%)

Earnings Before Tax (EBT)

-$69,410,000 (-33.67%)

-$51,925,000 (44.89%)

-$94,226,000 (66.59%)

-$282,024,000 (26.72%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$9,523,000 (-135.31%)

-$4,047,000 (90.64%)

-$43,259,000 (80.86%)

-$225,960,000 (34.18%)

Invested Capital

$71,082,000 (49.80%)

$47,452,000 (-52.53%)

$99,963,000 (21.06%)

$82,571,000 (-44.98%)

Working Capital

$32,917,000 (80.08%)

$18,279,000 (-67.15%)

$55,646,000 (451.06%)

$10,098,000 (-94.52%)

Tangible Asset Value

$161,626,000 (10.24%)

$146,617,000 (-34.82%)

$224,926,000 (-37.90%)

$362,176,000 (-18.60%)

Market Capitalization

$414,544,284 (77.46%)

$233,602,875 (120.08%)

$106,146,122 (-73.16%)

$395,410,533 (-2.30%)

Average Equity

-$40,149,750 (-44.47%)

-$27,791,250 (-203.41%)

$26,874,750 (-82.07%)

$149,920,000 (-54.99%)

Average Assets

$218,371,250 (-13.28%)

$251,817,750 (-45.53%)

$462,277,000 (-22.05%)

$593,045,000 (-16.86%)

Invested Capital Average

$65,782,250 (5.11%)

$62,581,250 (-33.37%)

$93,929,000 (-25.35%)

$125,822,750 (-35.90%)

Shares

218,181,202 (15.81%)

188,389,415 (2.41%)

183,962,083 (5.14%)

174,960,413 (21.05%)